These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32297308)

  • 21. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003594. PubMed ID: 21069676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D; Hodson E; Craig J
    Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2004; (2):CD001533. PubMed ID: 15106158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy for IgA nephropathy in children.
    Alladin A; Hahn D; Hodson EM; Ravani P; Pfister K; Quinn RR; Samuel SM
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015060. PubMed ID: 38864363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD001533. PubMed ID: 12535410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials.
    Durkan AM; Hodson EM; Willis NS; Craig JC
    Kidney Int; 2001 May; 59(5):1919-27. PubMed ID: 11318964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for BK virus infection in kidney transplant recipients.
    Wajih Z; Karpe KM; Walters GD
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD013344. PubMed ID: 39382091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for minimal change disease in adults with nephrotic syndrome.
    Palmer SC; Nand K; Strippoli GF
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001537. PubMed ID: 18253993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
    Edwards Mayhew RG; Li T; McCann P; Leslie L; Strong Caldwell A; Palestine AG
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD014831. PubMed ID: 36315029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001533. PubMed ID: 15674881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-immunosuppressive treatment for IgA nephropathy.
    Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001533. PubMed ID: 17943754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.